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Abstract. Since October 2010, over 700,000 cholera cases have been reported in Haiti. We used data from laboratory-
based surveillance for diarrhea in Haiti to evaluate the sensitivity, specificity, and positive (PPV) and negative predictive
values (NPV) of the cholera case definitions recommended by the World Health Organization (WHO). From April 2012
to May 2013, we tested 1,878 samples from hospitalized patients with acute watery diarrhea; 1,178 (62.7%) yielded Vibrio
cholerae O1. The sensitivity and specificity of the WHO case definition for cholera in an epidemic setting were 91.3%
and 43.1%, respectively, and the PPV and NPV were 72.8% and 74.8%, respectively. The WHO case definition for
cholera in an area where cholera is not known to be present had lower sensitivity (63.1%) and NPV (55.1%) but higher
specificity (74.2%) and PPV (80.0%). When laboratory diagnostic testing is not immediately available, clinicians can
evaluate signs and symptoms to more accurately identify cholera patients.
INTRODUCTION
A cholera epidemic began in Haiti in October 2010. From
October 20, 2010 to December 31, 2013, 697,392 cholera cases
were reported to Haiti’s National Cholera Surveillance System
(NCSS).1 Currently in Haiti, all patients with acute watery
diarrhea who are treated at cholera treatment facilities
(CTFs) are reported as cases of cholera to the NCSS.2 Most
clinics and CTFs in Haiti lack on-site capacity to confirm
suspected cholera cases with laboratory diagnostics. This makes
syndromic case definitions essential, both for surveillance and
clinical purposes. However, cholera can be difficult to diag-
nose on clinical grounds alone.3,4 Results from the limited
testing conducted in Haiti show that a considerable percent-
age of reported syndromic cholera cases have tested negative
for cholera; a recent report of laboratory diagnostic testing of
patients who presented to four Haitian hospitals with acute
diarrhea from 2012–2013 showed that although 73% of over
5 years old with acute diarrhea had laboratory-confirmed
cholera, only 26% of patients < 5 years old with acute diarrhea
had laboratory-confirmed cholera.5 Similar work conducted in
Haiti from 2011 to 2012 found that 41.8% of the patients sam-
pled who came to a cholera treatment center and 19.8% of
those seen in the community oral rehydration points had acute
diarrhea caused by cholera.6 Similarly, during the first months
of the cholera outbreak in the Dominican Republic in 2010,
less than one-fifth of suspected cholera cases were positive for
cholera by culture.7
It has been over 4 years since the cholera epidemic began in
Haiti. As the epidemic matures, having a better understanding
of the accuracy of different sign and symptom combinations in
accurately diagnosing laboratory-confirmed cholera is impor-
tant to inform national surveillance guidelines and clinical deci-
sion making. We used data from a laboratory-based sentinel
surveillance system for acute diarrheal illness in Haiti, which
complements NCCS, to evaluate the sensitivity, specificity, posi-
tive predictive value (PPV), and negative predictive value (NPV)
of the two case definitions recommended by World Health
Organization (WHO) for cholera surveillance (Figure 1), and
other combinations of clinical signs and symptoms.
MATERIALS AND METHODS
We used data from laboratory-based surveillance being
conducted at selected four hospitals.5 The first two hospitals,
Hôpital Universitaire De La Paix (HUP) and Hôpital Foyer
Saint Camille (HSC), are located in the capital of Haiti, Port-
au-Prince, in the west department. The third site, Hôpital
Saint Nicolas (HSN) de Saint Marc, is in the Artibonite
Department, and the fourth, Hôpital Saint Michel de Jacmel
(SMJ), is in the southeast department (Figure 2). We chose
these four hospitals because they all have associated CTFs,
have relatively large facilities, and are located within a 3-hour
drive from Laboratoire Nationale de Sante Publique (LNSP)
in Port-au-Prince, making transport of specimens manage-
able. At each site, trained nurses used convenience sampling
to collect stool specimens from up to 10 hospitalized patients
per week with acute watery diarrhea defined as three or more
episodes of acute watery diarrhea within 24 hours, with onset
of symptoms within the past 7 days.5 Patients who had taken
antibiotics either at home or in the health facility were
excluded. Patients were selected from CTFs, pediatric wards,
medicine wards, and emergency rooms. We also administered
a questionnaire to patients to collect demographic and clinical
information. Nurses determined a patient’s clinical symptoms,
including dehydration status, by a combination of chart review,
questions, and physical exam. Dehydration status was defined
according to WHO case definitions (http://whqlibdoc.who.int/
publications/2005/9241593180.pdf). Moderate dehydration was
defined as restless or irritable behavior, poor skin turgor,
rapid pulse, and moderate increase in thirst. Severe dehydra-
tion was defined as a lethargic or comatose patient with a
rapid and weak pulse, very poor skin turgor, and a major
increase in thirst.
Whole stool was collected in a cup, and two swabs were
placed into Cary-Blair transport medium. Whole stool and
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inoculated transport medium were stored at 2–8°C for up to
3 days before transport to LNSP. At LNSP, specimens were
tested by culture for V. cholerae, as described previously.5
Data Analysis. Data were entered and stored in a Microsoft
Access 2010 database (Microsoft Corporation, Redmond,
WA) and analyzed using Epi Info 7 (U.S. Centers for Disease
Control and Prevention [CDC], Atlanta, GA). Frequency pro-
cedures were used to generate descriptive statistics. Bivariate
and multivariate analyses were conducted to assess whether
demographic characteristics and clinical symptoms of patients
were associated with culture-positive cholera. Only symptoms
and characteristics known to be associated with cholera that
were present in > 20% patients tested for cholera were
included in the analyses. Symptoms and characteristics that
were statistically significant were included in a multivariable
model, and two-way interactions were assessed. We then eval-
uated the sensitivity, specificity, PPV, and PPV of the two
WHO case definitions and additional combinations of demo-
graphic characteristics and clinical symptoms using cholera
culture as the gold standard (Figure 3). The various case def-
initions were evaluated for patients of all ages, as well as
patients under 5 years.
Verbal consent was obtained from adults and from the
parents or guardians of minors. The verbal consent proce-
dures and the rest of the activities described in this evaluation
were approved as part of a non-research surveillance activity
by both the CDC Institutional Review Board and the Haiti
National Bioethics Committee.
RESULTS
Demographic characteristics. FromApril 2, 2012 to May 14,
2013, a total of 1,878 stool samples were collected from
patients presenting with acute watery diarrhea at the four
sentinel sites (Table 1). Almost half of sampled patients were
female (47.7%). The median age was 29 years, and most
patients (78.4%) were aged 5 years or older. Of the 1,878 sam-
ples tested by culture, 1,178 (62.7%) yielded V. cholerae.
Figure 1. WHO standard case definitions for cholera surveillance.8
Figure 2. Laboratory-based sentinel surveillance sites, Haiti, 2012–2013.
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A higher percentage of patients over 5 years (72.8%)
tested positive for cholera compared with patients under
5 years (25.2%).
Clinical symptoms and cholera. Bivariate analyses revealed
a significant association between age ³ 5 years and culture-
positive cholera (odds ratio [OR]: 8.0, 95% confidence inter-
val [CI]: 6.2–10.3) (Table 2). Moderate dehydration alone was
not significantly associated with culture-positive cholera (OR:
1.0, 95% CI: 0.5–1.7), however severe dehydration was (OR:
3.0, 95% CI: 1.7–5.3). Muscle pain (OR: 1.6, 95% CI: 1.3–2.0),
nausea (OR: 1.9, 95% CI: 1.5–2.3), and vomiting (OR: 3.3,
95% CI: 2.6–4.3) were all significantly associated with cholera.
In terms of the number of stools in the past 24 hours, patients
with 10–14 (OR: 5.2, 95% CI: 3.0–9.2), 15–19 (OR: 5.2, 95%
CI: 2.9–9.3), 20–24 (OR: 12.2, 95% CI: 6.5–22.9), and 25 or
more stools (OR: 10.3, 95% CI: 5.3–19.9) had significantly
higher odds of having culture-positive cholera compared with
patients who had 3–4 stools in the past 24 hours. Neither
abdominal pain nor the number of days of diarrhea was sig-
nificantly associated with culture-positive cholera. With the
exception of nausea and muscle pain, all symptoms that were
significant in bivariate analyses remained significant in multi-
variate analyses.
Sensitivity, specificity, PPV, and NPV of case definitions.
The sensitivity and specificity of the WHO case definition for
cholera in an epidemic setting (a patient aged 5 years or more
develops acute watery diarrhea, with or without vomiting) were
91.3% (95% CI: 89.6–92.8) and 43.1% (95% CI: 39.5–46.8),
respectively, and the PPV and NPV were 72.8% (95%
CI: 70.5–76.1) and 74.8% (95% CI: 70.3–78.8), respectively
(Table 3).8 The WHO case definition for cholera in an area
where the disease is not known to be present (a patient aged
5 years or more develops severe dehydration or dies from
acute watery diarrhea) had a lower sensitivity (63.1%, 95%
CI: 60.1–66.0) and NPV (55.1%, 95% CI: 51.8–58.5) but a
higher specificity (74.2%, 95% CI: 70.7–77.5) and PPV
(80.0%, 95% CI: 77.1–82.7). When we added moderate dehy-
dration to the latter WHO case definition, the sensitivity and
specificity were 88.7% (95% CI: 86.6–90.5) and 47.7% (95%
CI: 43.8–51.6), respectively.
Of all the combinations we explored among patients of all
ages, modifying the current syndromic case definition to include
only cases ³ 5 years old (the recommended WHO case defini-
tion for cholera epidemic areas) achieved a very high sensitiv-
ity for cholera (91.3%). Further restricting the definition to
include only cases ³ 5 years old with moderate to severe
diarrhea only minimally decreased the sensitivity to 88.7%.8
In contrast, adding muscle pain, nausea, vomiting, increasing
the number of stools in 24 hours, and limiting the case defini-
tion to severely dehydrated patients reduced the sensitivity of
the case definition considerably but also increased specificity.
The combination of age ³ 5 years, severe dehydration, and an
increased (³ 25) number of stools per 24 hours achieved the
highest specificity (99.5%, 95% CI: 98.3–99.9) and PPV
(92.0%, 95% CI: 75.0–97.8).
Among patients under 5 years, a case definition including
all patients with moderate or severe dehydration achieved the
highest sensitivity (98.9, 95% CI: 94.1–99.8) (Table 4). Similar
to results for patients of all ages, the addition of vomiting,
nausea, or muscle pain or increasing the threshold for the num-
ber of stools in the last 24 hours led to lower sensitivities but
higher specificities. The inclusion of muscle pain or a high
number of stools in particular led to high specificities and PPVs.
DISCUSSION
To the best of our knowledge this is the first study to look at
the statistical measures of performance of different combina-
tions of demographic characteristics, clinical signs, and symp-
toms, including the case definitions currently recommended
by WHO, for cholera surveillance.8 A similar assessment has
been carried out with regards to the WHO-recommended
Figure 3. The calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
Table 1
Characteristics of hospitalized patients tested for Vibrio cholerae,
Haiti, 2012–2013*
Patient characteristic Total tested for cholera N (%)
Age
< 5 years 401 (21.6)





Hôpital Universitaire de la Paix 673 (35.8)
Hôpital Foyer Saint-Camille 398 (21.2)
Hôpital Saint-Nicolas 440 (23.4)
Hôpital Saint-Michel de Jacmel 367 (19.5)
Total 1878 (100.0)
*Missing values excluded.
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case definition for typhoid fever.9 In Haiti, where cholera has
circulated widely since October 2010 and in other countries
where laboratory testing of every suspected cholera case is
either impractical or inefficient, our findings can help inform
decisions about how to optimize syndromic cholera case defi-
nitions to meet surveillance and clinical objectives.
We found that the WHO case definition for cholera in an
epidemic setting demonstrated a high sensitivity and a mod-
erate specificity. If the goal were to obtain a more specific
case definition than the one currently used by NCSS in Haiti,
this case definition could be an option. Although the highly
significant association between age group and cholera status
that was found in our bivariate analyses provides strong sup-
port for the exclusion of children < 5 years old from the case
definitions recommended by WHO, such a switch to this case
definition would certainly lead to missed cholera cases. The
current case definition for cholera in Haiti (a patient of any
age with acute watery diarrhea) likely falsely classifies many
diarrhea cases as cholera, particularly among children < 5 years
old.5 Nonetheless, in our four sites, 25.2% children < 5 years
old with acute diarrhea had culture-confirmed cholera. NCSS
has collected information on the age group (³ 5 versus < 5 years
old) of reported cholera patients since the beginning of the
epidemic.2 As of December 31, 2013, children < 5 years old
had accounted for 13.5% of 697,392 total reported cholera
cases. This age group continues to be susceptible to cholera
in Haiti, and as Haiti transitions from an epidemic pattern to a
more endemic pattern of cholera transmission, young children
with no previous exposure or prior immunity may eventually
comprise an even greater proportion of all cholera hospitali-
zations, as occurs in other countries.10,11
We found that a number of sign and symptom combinations
could provide higher levels of specificity for cholera surveil-
lance in Haiti. However, as expected, our findings also show
that modifying the current case definition or those recom-
mended by WHO to a more specific one would come at the
price of sensitivity. For an epidemic-prone disease such as
cholera, a surveillance system with low sensitivity could fail
to detect small outbreaks, and potentially delay mobilization
of life-saving clinical resources such as IV fluids and preven-
tive measures. Changing a surveillance case definition can
have important methodological and political implications.
For example, the apparent reduction in the number of cases
that would occur with a switch to the WHO case definition for
epidemic areas could lead to a false sense of security or
reduced resources for response and prevention efforts. In addi-
tion, such a change would complicate the comparison of new
data with historic data and analyses of trends across time.
Beyond cholera surveillance, the results of our analysis could
potentially provide further guidance for clinicians who treat
suspected cholera cases without laboratory diagnostic tools.
We found an association between several symptoms—muscle
pain, nausea, vomiting, and the number of stools in the past
24 hours—and culture-positive cholera among diarrhea
patients. These clinical symptoms are typical of cholera and
have been described previously.12 Our findings related to the
PPV and NPV of different sign and symptom combinations
could be especially useful in areas where treatment resources
are limited. Ultimately, the treatment of patients with diarrhea
depends largely on the degree of dehydration and not the eti-
ology. However, there are scenarios in which a better under-
standing of the etiology could prove useful. For example,
Table 2
Bivariate analyses of clinical symptoms and characteristics of hospitalized patients tested for Vibrio cholerae, Haiti, 2012–2013*
Characteristic/symptom Cholera positive N (%) Cholera negative N (%) OR 95% CI P value
Age group
< 5 years 101 (72.8) 300 (27.2) Ref.
5 years 1062 (25.2) 396 (74.8) 8.0 6.2–10.3 < 0.01
Dehydration
No dehydration 25 (48.1) 27 (51.9) Ref.
Moderate 308 (47.0) 347 (53.0) 1.0 0.5–1.7 0.88
Severe 695 (73.7) 248 (26.3) 3.0 1.7–5.3 < 0.01
Abdominal pain
Yes 856 (67.2) 417 (32.8) 1.2 1.0–1.5 0.11
No 309 (63.2) 180 (36.8) Ref.
Muscle pain
Yes 317 (74.4) 109 (25.6) 1.6 1.3–2.0 < 0.01
No 842 (64.6) 461 (35.4) Ref.
Nausea
Yes 807 (70.4) 339 (29.6) 1.9 1.5–2.3 < 0.01
No 359 (56.1) 281 (43.9) Ref.
Vomiting
Yes 1045 (68.2) 487 (31.8) 3.3 2.6–4.3 < 0.01
No 133 (39.1) 207 (60.9) Ref.
Days of diarrhea
1–2 638 (63.9) 361 (36.1) Ref.
3–5 365 (60.9) 234 (39.1) 0.9 0.7–1.1 0.24
6+ 31 (58.5) 22 (41.5) 0.8 0.5–1.4 0.43
Number of stools in last 24 hours
3–4 21 (29.6) 50 (70.4) Ref.
5–9 151 (41.5) 213 (58.5) 1.7 1.0–2.9 0.06
10–14 191 (68.7) 87 (31.3) 5.2 3.0–9.2 < 0.01
15–19 150 (68.5) 69 (31.5) 5.2 2.9–9.3 < 0.01
20–24 169 (83.7) 33 (16.3) 12.2 6.5–22.9 < 0.01
25+ 112 (81.2) 26 (18.8) 10.3 5.3–19.9 < 0.01
*Missing values excluded.
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antimicrobial treatment is recommended for cholera patients
with severe dehydration but not for rotavirus patients with
severe dehydration.13
Our findings should be considered in light of the fact that
sensitivity, specificity, PPV, and NPV can vary with disease
prevalence in the population.14 In Haiti, cholera activity
decreased in prevalence over the first three full years of the
epidemic: as of December 31, 2013 only 58,391 syndromic
cases had been reported, compared with 101,503 in 2012 and
352,033 in 2011.2 In other countries where cholera is endemic,
prevalence can also vary considerably. In Bangladesh, cholera
can be undetectable at certain times of the year, and in many
countries the magnitude of cholera epidemics varies dramati-
cally from year to year.15,16 Therefore, although our findings
may be applicable to other settings, they should be interpreted
in the context of the relevant prevalence of cholera.
Our findings are subject to several limitations. First, stool
samples were only collected from patients at four hospitals in
three departments, which limits the generalizability of the
results to the rest of the country. Second, stool samples were
collected from a convenience sample of hospitalized patients.
Only 55% of all cholera case reported to NCSS since the
beginning of the Haiti cholera epidemic were hospitalized.2
Our findings may not be applicable to outpatients. Although
all the four hospitals and their associated CTFs were located
in central locations within cities, it is possible that patients
with severe disease located further away from the hospitals
would have hadmore difficulty accessing the hospitals or CTFs,
which may have biased our results toward patients who lived
closer to the hospital. In addition, although we collected exten-
sive demographic and clinical information in our questionnaire,
there were some signs, such as rice-water stool, that were
omitted. This and other signs should be evaluated in future
studies. In addition, although all nurses were trained on iden-
tifying signs and symptoms associated with dehydration status,
classification may have varied by individual nurses. We also
only collected samples from patients with three or more epi-
sodes of acute watery diarrhea within 24 hours. However, over
70% infected persons can be asymptomatic, and would not
have been captured by this surveillance system; and therefore
our results are not applicable to asymptomatic cholera cases or
cholera cases with fewer than three episodes of diarrhea in a
day.17,18 In addition, although we instructed surveillance offi-
cers to do the best they could to evaluate whether the medica-
tions the patients said they had taken were in fact antibiotics,
which are easily available in Haiti outside the hospital, it is
possible that a small number of patients who took antibiotics
were included, and the inverse is possible as well. Finally,
Table 3
Sensitivity, specificity, PPV, and NPV of clinical case definitions for cholera, Haiti, 2012–2013*
Case definition†








(95% CI)A B C D
WHO case definitions
Age ³ 5 years 1062 396 101 300 91.3 (89.6–92.8) 43.1 (39.5–46.8) 72.8 (70.5–75.1) 74.8 (70.3–78.8)
Age ³ 5 years and severe dehydration 641 160 375 461 63.1 (60.1–66.0) 74.2 (70.7–77.5) 80.0 (77.1–82.7) 55.1 (51.8–58.5)
Moderate and severe dehydration
Severe dehydration 695 248 333 374 67.6 (64.7–70.4) 60.3 (56.2–63.9) 73.7 (70.8–76.4) 52.9 (49.2–56.6)
Moderate or severe dehydration 1003 595 25 27 97.6 (96.4–98.4) 4.3 (3.0–6.2) 62.8 (60.4–65.1) 51.9 (38.7–64.9)
Age ³ 5 years and moderate or severe dehydration 901 325 115 296 88.7 (86.6–90.5) 47.7 (43.8–51.6) 73.5 (71.0–75.9) 72.0 (67.5–76.1)
Nausea
Nausea 807 339 359 281 69.2 (66.5–71.8) 45.3 (41.4–49.3) 70.4 (67.7–73.0) 43.9 (40.1–47.8
Age ³ 5 years and nausea 738 250 413 367 64.1 (61.3–66.8) 59.5 (55.6–63.3) 74.7 (71.9–77.3) 47.1 (43.5–50.6)
Age ³ 5 years and severe dehydration and nausea 458 107 547 440 45.6 (42.5–48.7) 80.4 (76.9–83.6) 81.1 (77.6–84.1) 44.6 (41.5–47.7)
Vomiting
Vomiting 1045 487 133 207 88.7 (86.8–90.4) 29.8 (26.5–33.3) 68.2 (65.8–70.5) 60.9 (55.6–65.9)
Age ³ 5 years and vomiting 947 308 216 383 81.4 (79.1–83.6) 55.4 (51.7–59.1) 75.5 (73.0–77.8) 63.9 (60.0–67.7)
Age ³ 5 years and severe dehydration and vomiting 592 140 424 478 58.3 (55.2–61.3) 77.4 (73.9–80.5) 80.9 (77.9–83.6) 53.0 (49.7–56.2)
Muscle pain
Muscle pain 317 109 842 461 27.4 (24.9–30.0) 80.9 (77.5–83.9) 74.4 (70.1–78.3) 35.4 (32.8–38.0)
Age ³ 5 years and muscle pain 294 96 850 472 25.7 (23.3–28.3) 83.1 (79.8–86.0) 75.4 (70.9–79.4) 35.7 (33.2–38.3)
Age ³ 5 years and severe dehydration and muscle
pain
140 41 860 465 14.0 (12.0–16.3) 91.9 (89.2–94.0) 77.4 (70.7–82.8) 35.1 (32.6–37.7)
Number of stools in last 24 hours
³ 5 stools 773 428 21 50 97.4 (96.0–98.3) 10.5 (8.0–13.5) 64.4 (61.6–7.0) 70.4 (59.0–79.8)
³ 10 stools 622 215 172 263 78.3 (75.3–81.1) 55.0 (50.5–59.4) 74.3 (71.2–77.2) 60.5 (55.8–64.9)
³ 15 stools 431 128 363 350 54.3 (50.8–57.7) 73.2 (69.1–77.0) 77.1 (73.4–80.4) 49.1 (45.4–52.8)
³ 20 stools 281 59 513 419 35.4 (32.1–38.8) 87.7 (84.4–90.3) 82.7 (78.3–86.3) 45.0 (41.8–48.2)
³ 25 stools 112 26 682 452 14.1 (11.9–16.7) 94.6 (92.1–96.2) 81.2 (73.8–86.8) 39.9 (37.1–42.7)
Age ³ 5 years and ³ 5 stools 698 253 90 223 88.6 (86.2–90.6) 46.9 (42.4–51.3) 73.4 (70.5–76.1) 71.3 (66.0–76.0)
Age ³ 5 years and ³ 10 stools 580 171 208 305 73.6 (70.5–76.6) 64.1 (59.7–68.3) 77.2 (74.1–80.1) 59.5 (55.2–63.6)
Age ³ 5 years and ³ 15 stools 406 107 382 369 51.5 (48.0–55.0) 77.5 (73.6–81.0) 79.4 (75.4–82.4) 49.3 (45.6–52.7)
Age ³ 5 years and ³ 20 stools 268 51 520 425 34.0 (30.8–37.4) 89.3 (86.2–91.8) 84.0 (79.6–87.6) 45.0 (41.8–48.2)
Age ³ 5 years and ³ 25 stools 105 23 683 453 13.3 (11.1–15.9) 95.2 (92.9–96.8) 82.0 (74.5–87.7) 39.9 (37.1–42.8)
Age ³ 5 years and severe dehydration and ³ 5 stools 423 100 251 323 62.8 (59.1–66.3) 76.4 (72.1–80.2) 80.9 (77.3–84.0) 56.3 (52.2–60.3)
Age ³ 5 years and severe dehydration and ³ 10 stools 355 76 319 347 52.7 (48.9–56.4) 82.0 (78.1–85.4) 82.4 (78.5–85.7) 52.1 (48.3–55.9)
Age ³ 5 years and severe dehydration and ³ 15 stools 215 44 459 379 31.9 (28.5–35.5) 89.6 (86.3–92.2) 83.0 (78.0–87.1) 45.2 (41.9–48.6)
Age ³ 5 years and severe dehydration and ³ 20 stools 122 19 552 404 18.1 (15.4–21.2) 95.5 (93.1–97.1) 86.5 (79.9–91.2) 42.3 (39.2–45.4)
Age ³ 5 years and severe dehydration and ³ 25 stools 23 2 651 423 3.4 (2.3–5.1) 99.5 (98.3–99.9) 92.0 (75.0–97.8) 39.4 (36.5–42.3)
NPV = negative predictive value; PPV = positive predictive value.
*Missing values excluded.
†All case definitions include acute watery diarrhea.
‡Refer to Figure 3.
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although we used stool culture, the recognized gold standard
for cholera detection, we were not able to test specimens by
polymerase chain reaction (PCR).19 Although there is no cur-
rent consensus on a single, validated PCR method for cholera
diagnosis, the combined use of stool culture and PCR in future
studies could increase the sensitivity of cholera detection.20
More than 4 years after the beginning of the epidemic,
cholera remains an important public health issue in Haiti.
Improving access to safe drinking water and sanitation is the
best long-term solution to reducing morbidity and mortality
because of cholera and other diarrheal diseases. Oral cholera
vaccines may also have a role in cholera prevention and con-
trol in Haiti as a complement to more traditional measures. In
parallel, rigorous surveillance coupled with timely outbreak
response and effective clinical management can contribute to
saving lives. A simple, standardized case definition is central
to these efforts. No single case definition is perfect; public
health practitioners and policymakers must strike a balance
between sensitivity and specificity according to the objectives
of the surveillance system, which may change as cholera epi-
demics run their course over time. Although our work high-
lights several potential alternative case definitions for cholera
surveillance in Haiti, none stand out as a clear-cut, consensus
alternative, especially when weighing the practical and political
implications of modifying a case definition during an ongoing
epidemic. Nonetheless, our results can contribute to improv-
ing the understanding of the dynamics of the cholera epidemic
in Haiti.
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